CC BY-NC-ND
0J Ginseng Res xxx (2016) 1—7
10 11 12
20 21 22
Contents lists available at ScienceDirect
Journal of Ginseng Research
journal homepage: http://www.ginsengres.org
Mini-review article
Implications of red Panax ginseng in oxidative stress associated chronic diseases
q7 Yoon-Mi Lee, Haelim Yoon, Hyun-Min Park, Byeng Chun Song, Kyung-Jin Yeum*
Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju, South Korea
ARTICLE INFO
Article history: Received 14 December 2015 Received in Revised form 2 March 2016 Accepted 4 March 2016 Available online xxx
Keywords: antioxidant bioactives Panax ginseng red ginseng
ABSTRACT
The steaming process of Panax ginseng has been reported to increase its major known bioactive components, ginsenosides, and, therefore, its biological properties as compared to regular Panax ginseng. Biological functions of red Panax ginseng attenuating pro-oxidant environments associated with chronic diseases are of particular interest, since oxidative stress can be a key contributor to the pathogenesis of chronic diseases. Additionally, proper utilization of various biomarkers for evaluating antioxidant activities in natural products, such as ginseng, can also be important to providing validity to their activities. Thus, studies on the effects of red ginseng against various diseases as determined in cell lines, animal models, and humans were reviewed, along with applied biomarkers for verifying such effects. Limitations and future considerations of studying red ginseng were been discussed. Although further clinical studies are warranted, red ginseng appears to be beneficial for attenuating disease-associated symptoms via its antioxidant activities, as well as for preventing oxidative stress-associated chronic diseases.
Copyright © 2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Panax ginseng Meyer root has been considered as a medicinal plant in Eastern countries for thousands of years, and has been widely used for its health promotion in various disease conditions [1]. Panax ginseng can be classified by its processing methods and include fresh ginseng, white ginseng (air-dried), red ginseng (steamed), and sun ginseng. Notably, red ginseng, which is harvested at 6 yr, steamed, and then further dried, is well known for its elevated content of ginsenosides, which are bioactive compounds [2,3]. Red ginseng also exhibits various biological activities against chronic diseases, such as diabetes mellitus, cancer, and cardiovascular disease [4,5].
Red ginseng is composed of saponin (generally known as gin-senosides) and nonsaponin, including polysaccharides. The main active components in red ginseng are ginsenosides containing tri-terpene and sugar moieties [3]. Ginsenosides can be divided into three groups depending on their structures: (1) the panaxadiol group, including Rb1, Rb2, Rb3, Rc, Rd, Rg3, and Rh2; (2) the pan-axatriol group, including Re, Rf, Rg1, Rg2, and Rh1; and (3) the oleanolic acid group, including Ro, as shown in Fig. 1 [1]. The amount of ginsenosides vary according to harvest time, storage
condition, and processing methods [1]. Although there are other Panax species, such as Panax notoginseng, Panax japonicus, Panax quinquefolius, Panax pseudoginseng, and Panax vietnamensis as shown in Table 1, this review focuses on the biological activities of Panax ginseng.
2. Significance of proper determination of antioxidant activity
Certain levels of reactive oxygen species (ROS), such as superoxide, hydroxyl radical, and hydrogen peroxide, are necessary for crucial roles in differentiation, proliferation, and regulation of signal transduction in cells. ROS are constantly produced from mitochondria via the respiratory chain and the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system, and can be eliminated by enzymatic and non-enzymatic ROS scavenging factors, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), thio-redoxin, and NF-E2-related factor 2 (Nrf 2)-mediated expression of heme oxygenase 1 (HO-1), resulting in redox homeostasis [6,7]. However, impaired redox homeostasis results in excessive ROS, which is associated with the progression of several chronic
* Corresponding author. Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, 268 Chungwondaero, Chungju 27478, South Korea. E-mail address: kyeum@kku.ac.kr (K.-J. Yeum).
p1226-8453 e2093-4947/$ — see front matter Copyright © 2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/jogr.2016.03.003
60 61 62
80 81 82
99 100 101 102
110 111 112
118 119
J Ginseng Res 2016;m:1-7
10 11 12
20 21 22
60 61 62
Panaxadiol group
Panaxatriol group
glc (2—»1 )glc glc (2—»1 )glc glc (2—»1 )glc glc (2—»1 )glc glc (2—»1 )glc glc(2^1)glc glc
glc (6->l )glc glc (6->1)ara(p)
glc (6-1)xyl glc (6->1)ara(f) glc H H
Re glc (2->1)rha glc
Rf glc (2->1 )glc H
Rg, glc glc
Rg2 glc (2->1)rha H
Rh1 glc H
Oleanolic acid group
glc: glucopyranose ara(p): arabinopyranose xyl: xylopyranose ara(f): arabinofuranose rha: rhambopyranose glcUA: glucuronic acid
Ro glcUA (2->1)glc glc
Fig. 1. Structures of ginsenosides. Ginsenosides of Panax ginseng are classified into three groups according to their structures: panaxadiol, panaxatriol, and oleanolic acid groups.
diseases, such as diabetes, cancer, Alzheimer's disease, and cardiovascular diseases [8]. For these reasons, reducing oxidative stress by increased antioxidant intake is an attractive strategy for the prevention of such chronic diseases [9].
Proper biomarkers for oxidative stress validate the efficacy of red ginseng for evaluating the risk of chronic diseases. ROS determination in cells can be achieved by treatment with 2',7'-dichlroflurescein diacetate (DCF-DA). Oxidized DCF-DA is changed to 2',7'-dichlro-flurescein, which appears under fluorescence examination and can be detected by a microscope, flow cytometry, or microplate reader [10]. Oxidative modification of macromolecules (DNA, lipids, proteins, and carbohydrates) are used to assess levels of oxidative stress, because of the short-lived nature of ROS. Oxidation of the eighth guanine of DNA can be detected by 8-hydroxydeoxyguanosine (8-OHdG) in serum, urine, and tissue [11]. Additionally, phosphorylation of a histone H2A
Table 1
Origins of Panax species
Panax species Origin (habitat)
Panax ginseng Korea, China, Japan
Panax notoginseng China
Panax japonicus Japan
Panax quinquefolius Southern Canada, United States
Panax pseudoginseng Nepal and eastern Himalayas
Panax vietnamensis Vietnam
variant (H2AX) at Ser19 [12,13] can be determined by immunoblot-ting and immunohistochemistry in tissues as a novel biomarker for DNA damage by estimating the number of double-strand breaks. Comet assays (single-cell gel electrophoresis) also have been used for determination of DNA damage [14], which is closely related to cancer incidence [15].
Isoprostanes (IsoPs) and malondialdehyde (MDA) are byproducts of lipid peroxidation from arachidonic acid and poly-unsaturated fatty acid (PUFA), respectively [16]. Measurement of IsoPs in the plasma and urine can be performed by LC-MS, GC-MS, radioimmunoassay, and enzyme-linked immunosorbance assays (ELISA). MDA levels can be quantified through a reaction with thi-obarbituric acid (TBA), resulting in an MDA-TBA adduct that appears as colored end products. This process is known as a TBA-reacting substances (TBARS) assay [17]. Additionally, oxidized low-density lipoprotein (oxLDL) is associated with oxidative stress [16], and 4-hydroxy-2-nonenal (HNE) can be produced by oxygen attack on u-6-PUFA, which can make adducts with other macro-molecules [18]. The HNE forms a Michael adduct with Cys, Lys, and His residues on proteins, and these adducts serve as advanced lipoxidation/glycation end products that are closely associated with various chronic diseases, such as cardiovascular diseases, chronic obstructive pulmonary diseases, and neurodegenerative diseases [16,18,19]. The advanced glycation end products can bind to their receptors, resulting in promotion of inflammatory factor production, which in turn produces oxidative stress and irreversible
80 81 82
99 100 101 102
110 111 112
120 121 122
Y.-M. Lee et al / Antioxidant effects of red Panax ginseng
10 11 12
20 21 22
60 61 62
cellular dysfunction [20]. Additionally, protein modifications, such as nitrotyrosine and S-glutathionylation, can also be used as bio-markers for oxidative stress [16] (Fig. 2).
The antioxidant activity of red ginseng has been studied for several decades. Red ginseng water extracts were shown to scavenge free radicals, such as 1,1-dipheny-2-picrylhydrazyl, hydroxyl, superoxide, and carbon-centered radical in vitro [21]. Additionally, red ginseng water extract decreased ROS-induced bacterial plasmid DNA-strand breaks in vitro [22]. The antioxidant function of red ginseng has been suggested for health benefits.
3. Assessment of antioxidant activities of red ginseng in cells
Due to the feasibility of diverse approaches, the antioxidant activities of red ginseng have been studied extensively in cells (Table 2). Red ginseng has a protective effect against cisplatin-induce ototoxicity [23], and pretreatment with red ginseng extract (2.5 mg/mL, major constituents: Rb1, Rg1) before inducing ototoxicity by cisplatin-attenuated apoptosis in HO1-OC1 auditory cells inhibited ROS production. Additionally, treatment with red ginseng extract (0.5 mg/mL) upregulated Nrf-induced HO-1 in polychlorinated biphenyl (PCB) 126-treated PC12 rat pheochro-mocytoma cells [24]. Red ginseng also rescues cells from oxidative stress by increasing the concentration of antioxidant enzymes, such as SOD, CAT, and GPx in hydrogen peroxide-treated HepG2 hepatoma cells, indicating cytoprotective effects in the liver [25]. Oxidative stress occurs following ethanol treatment in hepatocytes, leading to severe liver damage. Red ginseng (1—1,000 mg/mL) and its ginsenosides (Rg3 and Rh2 at 1—30 mg/mL) mitigated to the hepatocytic injury by increasing its antioxidant capacity [26]. The
underlying mechanism of antioxidant activities associated with red ginseng is due to the downregulation of ROS-stimulated mitogen-activated protein kinase (MAPK) and Akt pathways [24—26]. When ROS was induced by hydrogen peroxide, the saponin fraction of red ginseng (50—100 mg/mL) significantly decreased ROS detected by DCF-DA assay and MDA levels, as well as improved antioxidant enzyme activities. It was suggested that saponin in red ginseng prevents oxidative stress-induced hepatic diseases, and that the effects were stronger as compared with those of white ginseng extract [27]. Additionally, red ginseng extract (1 mg/mL) eliminated arachiodonic acid + iron-induced oxidative stress in hepatocytes from diverse origins, including HepG2 (human), H411E (rat), and AML12 (mouse) cells. The inhibition of LKB1/AMP-activated protein kinases (AMPK) was reported to be a major mechanism associated with red ginseng antioxidant activity [28].
Studies of red ginseng in the area of neurodegenerative diseases have grown rapidly. Red ginseng water extract (0.3—3 mg/mL) blocked ROS generation and neuronal apoptosis, which was stimulated by glutamate, N-methyl-D-aspartate, or b-amyloid in rat cortical cells. These results implied the potential of red ginseng to aid in the prevention of neuronal diseases [29]. Additionally, red ginseng extract (0.01—1 mg/mL; major constituents: Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, and Rg3) was reported to have a neuroprotective effect on primary rat hippocampal neurons, where toxicity was induced by kainite, a glutamate analogue [30].
Helicobacter pylori has been studied as a causative bacteria that increases the risk of gastritis by triggering inflammation cascades. H. pylori-associated inflammation causes oxidative stress by recruiting neutrophils and macrophages to an infection site. Red ginseng extract (1—100 mg/mL; major constituents: Rb1, Rb2, Rc, Rd,
Biomarker Method
8-OHdG ELISA WB
P-H2AX IHC, WB
DNA tail length Comet assay
Carbohydrate
гф Lipid
Biomarker Method
IsoPs LC/MS, GC/MS, ELISA
MDA Colorimetric assay
4HNE ELJSA, IHC, WB
oxLDL ELISA
Biomarker Method
S-glutathionylation Flow cytometry,
microscopy
Nitrotyrosine ELJSA, IHC, WB
Carbonyls DPNH assay
Fig. 2. Biomarkers for oxidative stress and their analytical methods. 4HNE, 4-hydroxy-2-nonenal; 8-OHdG, 8-hydroxydeoxyguanosine; AGEs, advanced glycation end products; ALEs, advanced lipoxidation end products; DPNH, 2,4-dinitrophenyl-hydrazine; ELISA, enzyme-linked immunosorbent assay; IHC, immunohistochemistry; IsoPs, isoprostanes; MDA, malondialdehyde; oxLDL, oxidized low-density lipoprotein; WB, western blot.
80 81 82
99 100 101 102
110 111 112
120 121 122
J Ginseng Res 2016;ш:1-7
10 11 12
16 il 1S
20 21 22
26 2l 2S
36 3l 3S
46 4l 4S
56 Sl SS
60 б1 б2
Table 2
List of studies showing antioxidant activity of red ginseng in cells
Disease model Inducer Cell line Red ginseng type Antioxidant biomarker Ref
Ototoxicity Cisplatin HE1-OC1 Red ginseng DCF Y 23
(mouse auditory cell) water extract
Pheochromocytoma PCB126 PC12 cell Red ginseng extract DCF Y 24
(rat adrenal gland) GCLC, SOD, catalase [
Nrf2, HO-1 [
Hepatic disease H2O2 HepG2 cell Red ginseng essential oil DCF Y 25
(human hepatoma cell) SOD, GPx, CAT [
TBARS Y
Hepatic disease Ethanol T1B-73 cell Red ginseng DCF Y 26
(mouse hepatocyte) water extract
Rg3, Rh2
Hepatic disease H2O2 HepG2 cell Red ginseng DCF Y 2l
(human hepatoma cell) methanol extract MDA Y
GPx, GR, CAT, SOD[
Hepatic disease AA+ iron HepG2 cell Red ginseng extract DCF Y 28
(human hepatoma cell) GSH [
(rat hepatoma cell)
(mouse hepatocyte)
Neurodegenerative Glutamate Rat cortical cell Red ginseng DCF Y 29
disease NMDA water extract
ß-amyloid
Neurodegenerative Hippocampal Neuronal cell Red ginseng extract DCF Y 30
disease
Gastritis Helicobacter pylori AGS Red ginseng DCF Y 31
(human gastric epithelial cell) water extract NADPH oxidase activity Y
Oral mucositis Radiation HaCaT Red ginseng DCF Y З2
(human keratinocytes) water extract
Vascular disease Acrolein HUVECs Red ginseng DCF Y ЗЗ
(human umbilical vein endothelial cells) water extract
Vascular disease H2O2 HUVECs Red ginseng TRX1 [ З4
(human umbilical vein endothelial cells) water extract DCF Y
Diabetes Cytokine MIN6N8 Red ginseng extract DCF Y 35
(mouse pancreatic
ß-cells)
AA, arachiodonic acid; CAT, catalase; DCF, 2',7'-dichlroflurescein; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, glutathione; HO-1, heme oxygenase 1; MDA, malondialdehyde; NADPH, nicotinamide adenine dinucleotide phosphate; NMDA, N-methyl-D-aspartate; PCB126, polychlorinated biphenyls; SOD, superoxide dismutase; TBARS, thiobarbituric acid-reacting substances; TRX, thioredoxin reductase.
Re, Rf, Rgl, Rg2, Rg3, and Rhl) reduced expression of inflammatory factors by suppressing NADPH oxidase activity and Jak2/Stat3 in AGS human gastric epithelial cells [31]. Furthermore, treatment with red ginseng (10—50 mg/mL) was beneficial to enhancing cell survival under radiation exposure by inhibiting ROS generation and activation of the MAPK signaling pathways [32].
In an in vitro model of vascular diseases, red ginseng extract (0.5—2 mg/mL) exhibited a protective effect on oxidative stress-induced cell death in endothelial cells by upregulating thioredoxin reductase 1 and downregulating ROS generation, p38, and PKC-5 expression in endothelial cells damaged by a,b-unsaturated aldehyde acrolein and hydrogen peroxide [33,34].
Furthermore, red ginseng extract (0—100 mg/mL) was effective at inhibiting cytokine-induced cell death by downregulating apoptosis cascades and ROS production in M1N6N8 cells and pancreatic b cells. In particular, ginsenosides at low concentrations of 0.1—1.0 mg/mL were responsible for such activity, introducing he possibility for red ginseng use in diabetic treatments [35].
4. Assessment of antioxidant activities of red ginseng in animal models
Aging is closely related to oxidative stress and is related to physiological status [36]. Therefore, various red ginseng studies evaluated biomarkers of oxidative stress in young versus aged animals, as well as sexual dysfunction and kidney dysfunction (Table 3). Aged rats fed red ginseng water extract (200 mg/kg/d; major constituents: Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, and Rh1)
exhibited a significant reduction in oxidative stress as determined by MDA, as well as elevated concentration of antioxidant factors, such as SOD, CAT, GPx, glutathione reductase (GR), glutathione-S-transferase (GST), reduced glutathione, vitamin C, and vitamin E in various organs [37].
As male adults become older, one physical problem is sexual dysfunction. Red ginseng intake (200 mg/kg/d) in aged rats restored sexual function as estimated by enhancement of both sperm maturation and impaired testicular functions. The underlying mechanism for these alterations was revealed to be due to the antioxidant functions of red ginseng. Rats fed with red ginseng also displayed reduced MDA levels, while enzymatic and non-enzymatic antioxidants were elevated [38]. Other symptoms observed in aging rats was renal dysfunction; however one study showed that red ginseng treatment (200 mg/kg/d; major constituents: Rg1, Rb1, Rg3, Re, Rc, Rb2, and Rd) rescued oxidative-stress damaged renal tissue as detected by 8-OHdG and advanced glyca-tion end-product levels [39]. As listed in Table 3, red ginseng oil (10—50 mg/kg/d)-fed mice exhibited improvements in carbon tetrachloride (CCl4)-damaged liver tissue following upregulation of antioxidant capacity, as well as downregulation of the MAPK pathway [25]. Additionally, rats administered 250mg/kg/d red ginseng extract prior to injection of aflatoxin B1 to induce hepato-cyte damage showed decreased apoptosis levels in liver tissue and elevated antioxidant enzyme levels [40]. Red ginseng extract treatment (250—500 mg/kg/d) also relieved symptoms of fatty liver induced by chronic exposure to ethanol. In this study, lipid perox-idation as determined by 4-HNE and oxidative-protein
бб б! 6S
ll lS l9 SO В1 В2 S3 В4 85 Вб 8l 88
96 9l 9S 99
100 101 102
106 10l 108
110 111 112
116 11l 118
120 121 122
126 12l 128
Y.-M. Lee et al / Antioxidant effects of red Panax ginseng
Table 3
List of studies showing antioxidant activity of red ginseng in animals (rodents)
Disease model Inducer Red ginseng type Antioxidant biomarker Ref
Aging 12-mo old Red ginseng water extract MDA Y SOD, CAT, GPx, GR, GST [ GSH, Vit C, Vit E [ 37
Age-related male sexual dysfunction 12-mo old Red ginseng water extract MDA Y SOD, CAT, GPx, GR, GST [ GSH, Vit C, a-tocopherol [ 38
Age-related renal injury HFD, D-galactose Red ginseng 8-OHdG Y AGE Y 39
Hepatic disease CCI4 Red ginseng essential oil TBARS Y SOD, GPx, CAT [ 2S
Hepatic disease Aflatoxin B1 Red ginseng extract SOD, CAT, GPx [ MDA Y 4O
Alcoholic liver disease Ethanol Red ginseng water extract 4-HNE Y Nitrotyrosine Y 41
Diabetes Streptozotocin Fermented red ginseng extract GSH [ MDA Y SOD, CAT, GPx, GR [ 42
Diabetes Cyclosporine Red ginseng water extract 8-OHdG Y 43
Gastric ulcer Hydrochloride/Ethanol indomethacin Red ginseng powered extract containing drug TBARS Y 44
High intensive exercise Treadmill for 3 wks HRG MDA Y SOD [ 4S
Arthritis Murine type II collagen Red ginseng saponin extract MDA Y Nitrotyrosine Y SOD, GSH, CAT [ 46
Skin cancer 7,12-dimethylbenz(a)anthracene Croton oil Red ginseng hydroalcoholic extract GSH, SOD, CAT, Vit C [ TBARS Y 47
4HNE, 4-hydroxy-2-nonenal; 8-OHdG, 8-hydroxydeoxyguanosine; AA, arachiodonic acid; AGE, advanced glycation end product; CAT, catalase; DCF, 2',7'-dichlroflurescein; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, glutathione; HFD, high-fat diet; HRG, high pressure-treated red ginseng; HO-1, heme oxygenase 1; MDA, malondialdehyde; NADPH, nicotinamide adenine dinucleotide phosphate; NMDA, N-methyl-D-aspartate; PCB126, polychlorinated biphenyls; SOD, superoxide dismutase; TBARS, thiobarbituric acid-reacting substances; TRX, thioredoxin reductase; Vit, vitamin.
modifications evaluated by nitrotyrosine were both decreased. Furthermore, AMPK/Sirt1 levels were reported to be involved in the observed decrease in oxidative stress [41].
Fermented red ginseng extract (100—200 mg/kg/d) treatment of diabetic rats exerted antioxidant effects, and red ginseng (0.2— 0.4 mg/kg/d; major constituents: Rg1, Rb1, Rg3, Re, Rc, Rb2, Rd, Rf, Rh1, and Rg2) administration reduced cyclosporine-induced elevated 8-OHdG levels in mouse pancreas [42,43], indicating anti-diabetic effects.
Gastric ulcers can be induced by oral administration of hydro-chloride in ethanol or indomethacin in mice. Red ginseng treatment (30—300 mg/kg/d) with these drugs resulted in a decrease in ulcer area and TBARS [44]. Interestingly, high temperature- and high pressure-treated red ginseng (100 mg/kg/d)-fed mice ameliorated exercise-induced oxidative stress as compared with commercial red ginseng extracts (100 mg/kg/d) [45].
When saponin was fractionated from red-ginseng crude extract and administered to mice with arthritis, the red ginseng saponin extract (10 mg/kg/d; major constituents: Rg3, Rk1, and Rg5) reduced not only inflammatory factors, but also lipid peroxidation and nitrotyrosine levels. Additionally, the recovery of antioxidant enzymes in the liver and kidney that had been damaged by oxidative stress was also observed [46]. Furthermore, red ginseng (25 mg/kg/d; major constituents: Rb1 and Rg1) reduced incidence of skin cancer induced by 7,12-dimethylbenz(a)anthracene and croton oil through antioxidant mechanisms [47].
5. Assessment of antioxidant activities of red ginseng in humans
Biomarkers that were utilized to determine antioxidant activities of red ginseng in humans are listed in Table 4. Three grams of red ginseng per day and 6 g/d of red ginseng were randomly
allocated to healthy participants for 8 wk along with a placebo. The Q2 participants that ingested red ginseng displayed elevated levels of antioxidant enzymes that were greater than the placebo group, along with decreased levels of DNA damage (detected by alkaline comet assay) and lipid peroxidation (detected as oxLDL levels) [48].
Reduced estrogen levels in postmenopausal women are associated with high-risk of cardiovascular diseases. Postmenopausal women who ingested 3 g/d of red ginseng for 12 wk displayed higher concentrations of antioxidant enzymes relative to the placebo group. Furthermore, serum MDA levels were also reduced, although ingestion of red ginseng had no effect on serum 8-OHdG levels [49].
6. Limitations and perspectives
There have been limited studies on the antioxidant activity of red ginseng in humans. Although ginseng has been regarded as safe [50,51], several studies warned about adverse effects of red ginseng, including allergies and toxicity to the heart, kidney, liver, and reproductive organs [52]. Additionally, depending on the processing method, the amount and type of ginsenosides vary. Therefore, application of red ginseng in humans requires
Table 4
List of studies showing antioxidant activity of red ginseng in humans
Participants
Red ginseng type Antioxidant Biomarker Ref
Healthy participants Capsule containing SOD, CAT, GPx [ red ginseng DNA tail length Y
oxLDL Y
Postmenopausal women Capsule containing SOD [ 49
red ginseng MDA Y
CAT, catalase; GPx, glutathione peroxidase; MDA, malondialdehyde; oxLDL, oxidized low-density lipoprotein; SOD, superoxide dismutase.
111 112
121 122
J Ginseng Res 20í6;-:í-7
10 11 12
16 1l 1S
20 21 22
26 2l 2S
46 4l 4S
56 Sl SS
60 б1 б2
development of a standard processing method and various other controlled conditions, such as proper daily dose duration and accurate determination of patient health status. As previously described, red ginseng is produced through a process of steaming and drying of white ginseng, resulting in improved stability and elevated ginsenoside content [53]. Despite its reported health benefits, studies on red ginseng are still limited in Asia, in contrast to worldwide studies on white ginseng. Therefore, further studies on the efficacy of red ginseng in Western countries and direct comparison with white ginseng regarding their reported functions are necessary.
1n summary, red ginseng and ginsenosides, the major bioactive constituents in red ginseng, have biological functions ameliorating various disease symptoms via antioxidant mechanisms in cells and animals (especially in rodents). Although, there are limitations with respect to human studies on the effect of red ginseng, ingestion of red ginseng has also been shown to improve antioxidant activities in humans determined by various biomarkers of oxidative stress. Taken together, ingestion of red ginseng can be a preventive strategy against oxidative stress associated chronic diseases.
Conflicts of interest
None declared.
Q3 Acknowledgments
This study was supported in part by The Korean Society of Ginseng (2014).
Q4 References
[9 [10 [11
[12 [13 [14 [15
[1l [1S
Radad K, Gille G, Liu L, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006;100:175—86. Bae JS, Park HS, Park JW, Li SH, Chun YS. Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling. J Nat Med 2012;66:476—85.
Choi YJ, Choi H, Cho CH, Park JW. Red ginseng deregulates hypoxia-induced genes by dissociating the H1F-1 dimer. J Nat Med 2011;65:344—52. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259—74.
Wong VK, Cheung S, Li T, Jiang ZH, Wang JR, Dong H, Yi XQ, Zhou H, Liu L. Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-kappaB signaling. J Cell Bio-chem 2010;111:899—910.
Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009;8: 579—91.
Chen K, Gunter K, Maines MD. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 2000;75:304—13. Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009;3:73—80.
Finkel T. Signal transduction by reactive oxygen species. J Cell Biol 2011;1:7— 15.
Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002;265:49—72. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clinica Chimica Acta 2004;339:1—9.
Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 2012;920:613—26.
Kuo LJ, Yang LX. Gamma-H2AX — a novel biomarker for DNA double-strand breaks. Vivo 2008;22:305—9.
Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 2006;1:23—9.
Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864—70.
Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 2013;1:483—91.
Meagher EA, FitzGerald GA. 1ndices of lipid peroxidation in vivo: strengths
and limitations. Free Radic Biol Med 2000;28:1745—70.
Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003;53:S26—33.
[19] Rahman 1, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer W1. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:490-5.
[20] SongBC, Joo NS, Aldini G, Yeum KJ. Biological functions of histidine-dipeptides and metabolic syndrome. Nutr Res Pract 2014;8:3-10.
[21] Kim YK, Guo Q, Packer L. Free radical scavenging activity of red ginseng aqueous extracts. Toxicology 2002;172:149-56.
[22] Park BJ, Lim YS, Lee HJ, Eum WS, Park J, Han KH, Choi SY, Lee KS. Antioxidative effects of Phellinus linteus and red ginseng extracts on oxidative stress-induced DNA damage. BMB Rep 2009;42:500-5.
[23] 1m GJ, Chang JW, Choi J, Chae SW, Ko EJ, Jung HH. Protective effect of Korean red ginseng extract on cisplatin ototoxicity in HE1-OC1 auditory cells. Phyt-other Res 2010;24:614-21.
[24] Park SH, JangJH, Chen CY, Na HK, Surh YJ. A formulated red ginseng extract rescues PC12 cells from PCB-induced oxidative cell death through Nrf2-mediated upregulation of heme oxygenase-1 and glutamate cysteine ligase. Toxicology 2010;278:131-9.
[25] Bak MJ, Jun M, Jeong WS. Antioxidant and hepatoprotective effects of the red ginseng essential oil in H(2)O(2)-treated hepG2 cells and CCl(4)-treated mice. 1nt J Mol Sci 2012;13:2314-30.
[26] Park HM, Kim SJ, Mun AR, Go HK, Kim GB, Kim SZ, Jang S1, Lee SJ, Kim JS, Kang HS. Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in T1B-73 cell. J Ethnopharmacol 2012;141:1071-6.
[27] Sohn SH, Kim SK, Kim YO, Kim HD, Shin YS, Yang SO, Kim SY, Lee SW. A comparison of antioxidant activity of Korean White and Red Ginsengs on H2O2-induced oxidative stress in HepG2 hepatoma cells. J Ginseng Res 2013;37:442-50.
[28] Dong GZ, Jang EJ, Kang SH, Cho 1J, Park SD, Kim SC, Kim YW. Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway. BMC Complement Altern Med 2013;13:64.
[29] Kim S, Lee Y, Cho J. Korean red ginseng extract exhibits neuroprotective effects through inhibition of apoptotic cell death. Biol Pharm Bull 2014;37:938-46.
[30] Han JY, Ahn SY, Oh EH, Nam SY, Hong JT, Oh KW, Lee MK. Red ginseng extract attenuates kainate-induced excitotoxicity by antioxidative effects. Evid Based Complement Alternat Med 2012;2012:479016.
[31] Cho SO, Lim JW, Kim H. Red ginseng extract inhibits the expression of MCP-1 and iNOS in Helicobacter pylori-infected gastric epithelial cells by suppressing the activation of NADPH oxidase and Jak2/Stat3. J Ethnopharmacol 2013;150: 761-4.
[32] Chang JW, Park KH, Hwang HS, Shin YS, Oh YT, Kim CH. Protective effects of Korean red ginseng against radiation-induced apoptosis in human HaCaT keratinocytes. J Radiat Res 2014;55:245-6.
[33] Park HR, Lee SE, Yang H, Son GW, Jin YH, Park YS. 1nduction of thioredoxin reductase 1 by Korean red ginseng water extract regulates cytoprotective effects on human endothelial cells. Evid Based Complement Alternat Med 2015;2015:972040.
[34] Lee SE, Park YS. Korean Red Ginseng water extract inhibits COX-2 expression by suppressing p38 in acrolein-treated human endothelial cells. J Ginseng Res 2014;38:34-9.
[35] Kim HY, Kim K. Protective effect of ginseng on cytokine-induced apoptosis in pancreatic beta-cells. J Agric Food Chem 2007;55:2816-23.
[36] Sahhugi Z, Hasenan SM, Jubri Z. Protective effects of gelam honey against oxidative damage in young and aged rats. Oxid Med Cell Longev 2014;2014: 673628.
[37] Ramesh T, Kim SW, Hwang SY, Sohn SH, Yoo SK, Kim SK. Panax ginseng reduces oxidative stress and restores antioxidant capacity in aged rats. Nutr Res 2012;32:718-26.
[38] Kopalli SR, Hwang SY, Won YJ, Kim SW, Cha KM, Han CK, Hong JY, Kim SK. Korean red ginseng extract rejuvenates testicular ineffectiveness and sperm maturation process in aged rats by regulating redox proteins and oxidative defense mechanisms. Exp Gerontol 2015;69:94-102.
[39] Park S, Kim CS, Min J, Lee SH, Jung YS. A high-fat diet increases oxidative renal injury and protein glycation in D-galactose-induced aging rats and its prevention by Korea red ginseng. J Nutr Sci Vitaminol 2014;60:159-66.
[40] Kim YS, Kim YH, Noh JR, Cho ES, Park JH, Son HY. Protective effect of Korean red ginseng against aflatoxin B1-1nduced hepatotoxicity in rat. J Ginseng Res 2011;35:243-9.
[41] Han JY, Lee S, Yang JH, Kim S, Sim J, Kim MG, Jeong TC, Ku SK, Cho 1J, Ki SH. Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation. J Ginseng Res 2015;39:105-15.
[42] Kim HJ, Lee SG, Chae 1G, Kim MJ, 1m NK, Yu MH, Lee EJ, Lee 1S. Antioxidant effects of fermented red ginseng extracts in streptozotocin- induced diabetic rats. J Ginseng Res 2011;35:129-37.
[43] Lim SW, Doh KC, Jin L, Piao SG, Heo SB, Zheng YF, Bae SK, Chung BH, Yang CW. Oral administration of ginseng ameliorates cyclosporine-induced pancreatic injury in an experimental mouse model. PloS ONE 2013;8:e72685.
[44] Oyagi A, Ogawa K, Kakino M, Hara H. Protective effects of a gastrointestinal agent containing Korean red ginseng on gastric ulcer models in mice. BMC Complement Altern Med 2010;10:45.
[45] Yu SY, Yoon BR, Lee YJ, Lee JS, Hong HD, Lee YC, Kim YC, Cho CW, Kim KT, Lee OH. 1nhibitory effect of high temperature- and high pressure-treated red ginseng on exercise-induced oxidative stress in 1CR mouse. Nutrients 2014;6: 1003-15.
бб 6l 68 б9
16 ll lS l9 80 S1 S2 83
96 9l 9S 99
100 101 102
106 10l 108
110 111 112
116 11l 11S
120 121 122
126 12l 12S
Y.-M. Lee et al / Antioxidant effects of red Panax ginseng
[46] Kim KR, Chung TY, Shin H, Son SH, Park KK, Choi JH, Chung WY. Red ginseng saponin extract attenuates murine collagen-induced arthritis by reducing pro-inflammatory responses and matrix metalloproteinase-3 expression. Biol Pharm Bill 2010;33:604-10.
[47] Sharma J, Goyal PK. Chemoprevention of chemical-induced skin cancer by Panax ginseng root extract. J Ginseng Res 2015;39:265-73.
[48] Kim JY, Park JY, Kang HJ, Kim OY, Lee JH. Beneficial effects of Korean red ginseng on lymphocyte DNA damage, antioxidant enzyme activity, and LDL oxidation in healthy participants: a randomized, double-blind, placebo-controlled trial. Nutr J 2012;11:47.
[49] Seo SK, Hong Y, Yun BH, Chon SJ, Jung YS, Park JH, Cho S, Choi YS, Lee BS. Antioxidative effects of Korean red ginseng in postmenopausal women: a
double-blind randomized controlled trial. J Ethnopharmacol 2014;154: 753-7.
[50] Park SJ, Lim KH, Noh H, Jeong EJ, Kim YS, Han BC, Lee SH, Moon KS. Subacute oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats. Toxicol Res 2013;29:285-92.
[51] Bak MJ, Kim KB, Jun J, Jeong WS. Safety of red ginseng oil for single oral administration in Sprague-Dawley rats. J Ginseng Res 2014;38:78-81.
[52] Paik DJ, Lee CH. Review of cases of patient risk associated with ginseng abuse and misuse. J Ginseng Res 2015;39:89-93.
[53] Huu Tung N, Uto T, Morinaga O, Kim YH, Shoyama Y. Pharmacological effects of ginseng on liver functions and diseases: a mini review. Evid Based Complement Alternat Med 2012;2012:173297. Q1
20 21 22
